-
1
-
-
14744278435
-
Perspectives for the management of febrile neutropenic patients with cancer in the 21st century
-
Sipsas NV, Bodey GP, Kontoyiannis DP. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer. 2005;103:1103-1113.
-
(2005)
Cancer
, vol.103
, pp. 1103-1113
-
-
Sipsas, N.V.1
Bodey, G.P.2
Kontoyiannis, D.P.3
-
2
-
-
33645302916
-
Current approaches to diagnosis and treatment of invasive aspergillosis
-
Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006;173:707-717.
-
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 707-717
-
-
Segal, B.H.1
Walsh, T.J.2
-
3
-
-
0037087226
-
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
-
Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
-
(2002)
Clin Infect Dis.
, vol.34
, pp. 730-751
-
-
Hughes, W.T.1
Armstrong, D.2
Bodey, G.P.3
-
4
-
-
0032888684
-
Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival
-
Groll AH, Kurz M, Schneider W, et al. Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses. 1999;42:431-442.
-
(1999)
Mycoses
, vol.42
, pp. 431-442
-
-
Groll, A.H.1
Kurz, M.2
Schneider, W.3
-
5
-
-
0033512462
-
Aspergillosis in children with cancer: A 34-year experience
-
Abbasi S, Shenep JL, Hughes WT, et al. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis. 1999;29:1210-1219.
-
(1999)
Clin Infect Dis
, vol.29
, pp. 1210-1219
-
-
Abbasi, S.1
Shenep, J.L.2
Hughes, W.T.3
-
6
-
-
0033757977
-
Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years
-
Hovi L, Saarinen-Pihkala UM, Vettenranta K, et al. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant. 2000;26:999-1004.
-
(2000)
Bone Marrow Transplant
, vol.26
, pp. 999-1004
-
-
Hovi, L.1
Saarinen-Pihkala, U.M.2
Vettenranta, K.3
-
7
-
-
0033847078
-
Prospective study on fungemia in children with cancer: Analysis of 35 cases and comparison with 130 fungemias in adults
-
Krupova Y, Sejnova D, Dzatkova J, et al. Prospective study on fungemia in children with cancer: analysis of 35 cases and comparison with 130 fungemias in adults. Support Care Cancer. 2000;8:427-430.
-
(2000)
Support Care Cancer
, vol.8
, pp. 427-430
-
-
Krupova, Y.1
Sejnova, D.2
Dzatkova, J.3
-
8
-
-
1542327728
-
Candida infections in children treated with conventional chemotherapy for solid tumors (transplant recipients excluded): The Institut Gustave Roussy Pediatrics Department experience
-
Ridola V, Chachaty E, Raimondo G, et al. Candida infections in children treated with conventional chemotherapy for solid tumors (transplant recipients excluded): the Institut Gustave Roussy Pediatrics Department experience. Pediatr Blood Cancer. 2004;42:332-337.
-
(2004)
Pediatr Blood Cancer
, vol.42
, pp. 332-337
-
-
Ridola, V.1
Chachaty, E.2
Raimondo, G.3
-
9
-
-
0038613711
-
Nonalbicans candida is the most common cause of candidemia in pediatric cancer patients
-
Mullen CA, Abd El-Baki H, Samir H, et al. Nonalbicans candida is the most common cause of candidemia in pediatric cancer patients. Support Care Cancer. 2003;11:321-325.
-
(2003)
Support Care Cancer
, vol.11
, pp. 321-325
-
-
Mullen, C.A.1
Abd El-Baki, H.2
Samir, H.3
-
10
-
-
15444375213
-
Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution
-
Rosen GP, Nielsen K, Glenn S, et al. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J Pediatr Hematol Oncol. 2005;27:135-140.
-
(2005)
J Pediatr Hematol Oncol
, vol.27
, pp. 135-140
-
-
Rosen, G.P.1
Nielsen, K.2
Glenn, S.3
-
11
-
-
30944451379
-
Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic he-matopoietic cell transplantation
-
Dvorak CC, Steinbach WJ, Brown JM, et al. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic he-matopoietic cell transplantation. Bone Marrow Transplant. 2005;36:621-629.
-
(2005)
Bone Marrow Transplant
, vol.36
, pp. 621-629
-
-
Dvorak, C.C.1
Steinbach, W.J.2
Brown, J.M.3
-
12
-
-
33745698978
-
Fungal infections in children with cancer: A prospective, multicenter surveillance study
-
Castagnola E, Cesaro S, Giacchino M, et al. Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J. 2006;25:634-639.
-
(2006)
Pediatr Infect Dis J
, vol.25
, pp. 634-639
-
-
Castagnola, E.1
Cesaro, S.2
Giacchino, M.3
-
14
-
-
9844239388
-
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
-
Prentice HG, Hann IM, Herbrecht R, et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol. 1997;98:711-718.
-
(1997)
Br J Haematol
, vol.98
, pp. 711-718
-
-
Prentice, H.G.1
Hann, I.M.2
Herbrecht, R.3
-
17
-
-
0028140216
-
Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: The potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection
-
Francis P, Lee JW, Hoffman A, et al. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection. J Infect Dis. 1994;169:356-368.
-
(1994)
J Infect Dis
, vol.169
, pp. 356-368
-
-
Francis, P.1
Lee, J.W.2
Hoffman, A.3
-
18
-
-
0028988695
-
Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data
-
Ng TT, Denning DW. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data. Arch Intern Med. 1995;155:1093-1098.
-
(1995)
Arch Intern Med
, vol.155
, pp. 1093-1098
-
-
Ng, T.T.1
Denning, D.W.2
-
19
-
-
17044455920
-
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743 872)
-
Bartizal K, Gill CJ, Abruzzo GK, et al. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimi-crob Agents Chemother. 1997;41:2326-2332.
-
(1997)
Antimi-crob Agents Chemother
, vol.41
, pp. 2326-2332
-
-
Bartizal, K.1
Gill, C.J.2
Abruzzo, G.K.3
-
20
-
-
0033836270
-
Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclo-phosphamide-induced immunosuppressed mice
-
Abruzzo GK, Gill CJ, Flattery AM, et al. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclo-phosphamide-induced immunosuppressed mice. Antimicrob Agents Chemother. 2000;44:2310-2318.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 2310-2318
-
-
Abruzzo, G.K.1
Gill, C.J.2
Flattery, A.M.3
-
21
-
-
0036135430
-
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition and relationship to galactomannan antigenemia
-
Petraitiene R, Petraitis V, Groll AH, et al. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition and relationship to galactomannan antigenemia. Antimicrob Agents Chemother. 2002;46:12-23.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 12-23
-
-
Petraitiene, R.1
Petraitis, V.2
Groll, A.H.3
-
22
-
-
0033545538
-
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group
-
Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med. 1999;340:764-771.
-
(1999)
N Engl J Med
, vol.340
, pp. 764-771
-
-
Walsh, T.J.1
Finberg, R.W.2
Arndt, C.3
-
23
-
-
4644346490
-
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
-
Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004;351:1391-1402.
-
(2004)
N Engl J Med
, vol.351
, pp. 1391-1402
-
-
Walsh, T.J.1
Teppler, H.2
Donowitz, G.R.3
-
24
-
-
0036133373
-
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
-
Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 7-14
-
-
Ascioglu, S.1
Rex, J.H.2
De Pauw, B.3
-
25
-
-
0035909054
-
-
Boogaerts M, Winston DJ, Bow EJ, et al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial. Ann Intern Med. 2001;135:412-422.
-
(2001)
Intravenous and Oral Itraconazole Versus Intravenous Amphotericin B Deoxycholate As Empirical Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-spectrum Antibacterial Therapy. A Randomized, Controlled Trial. Ann Intern Med
, vol.135
, pp. 412-422
-
-
Boogaerts, M.1
Winston, D.J.2
Bow, E.J.3
-
26
-
-
0033972985
-
A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer
-
Winston DJ, Hathorn JW, Schuster MG, et al. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Am J Med. 2000;108:282-289.
-
(2000)
Am J Med
, vol.108
, pp. 282-289
-
-
Winston, D.J.1
Hathorn, J.W.2
Schuster, M.G.3
-
27
-
-
33645726603
-
Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: Analysis of results from the Caspofungin Empirical Therapy Study
-
de Pauw BE, Sable CA, Walsh TJ, et al. Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study. Transpl Infect Dis. 2006;8:31-37.
-
(2006)
Transpl Infect Dis
, vol.8
, pp. 31-37
-
-
De Pauw, B.E.1
Sable, C.A.2
Walsh, T.J.3
-
29
-
-
27644585388
-
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents
-
Walsh TJ, Adamson PC, Seibel NL, et al. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother. 2005;49:4536-4545.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 4536-4545
-
-
Walsh, T.J.1
Adamson, P.C.2
Seibel, N.L.3
-
30
-
-
34248160575
-
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
-
Cornely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007;44:1289-1297.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 1289-1297
-
-
Cornely, O.A.1
Maertens, J.2
Bresnik, M.3
-
31
-
-
32644466027
-
Treatment with caspofungin in immunocompromised paediatric patients: A multicentre survey
-
Groll AH, Attarbaschi A, Schuster FR, et al. Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey. J Antimicrob Chemother. 2006;57:527-535.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 527-535
-
-
Groll, A.H.1
Attarbaschi, A.2
Schuster, F.R.3
-
32
-
-
63149172257
-
A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients
-
Zaoutis T, Jafri H, Huang L, et al. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics. 2009;123:877-884.
-
(2009)
Pediatrics
, vol.123
, pp. 877-884
-
-
Zaoutis, T.1
Jafri, H.2
Huang, L.3
-
33
-
-
0031684378
-
Chest discomfort associated with liposomal amphotericin B: Report of three cases and review of the literature
-
Johnson MD, Drew RH, Perfect JR. Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature. Pharmacotherapy. 1998;18:1053-1061.
-
(1998)
Pharmacotherapy
, vol.18
, pp. 1053-1061
-
-
Johnson, M.D.1
Drew, R.H.2
Perfect, J.R.3
-
34
-
-
0038183841
-
A triad of acute infusion-related reactions associated with liposomal amphotericin B: Analysis of clinical and epidemiological characteristics
-
Roden MM, Nelson LD, Knudsen TA, et al. A triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics. Clin Infect Dis. 2003;36:1213-1220.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 1213-1220
-
-
Roden, M.M.1
Nelson, L.D.2
Knudsen, T.A.3
-
35
-
-
0042349758
-
Effects of amphotericin B and caspofungin on histamine expression
-
Cleary JD, Schwartz M, Rogers PD, et al. Effects of amphotericin B and caspofungin on histamine expression. Pharmacotherapy. 2003;23:966-973.
-
(2003)
Pharmacotherapy
, vol.23
, pp. 966-973
-
-
Cleary, J.D.1
Schwartz, M.2
Rogers, P.D.3
-
36
-
-
49449103740
-
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria
-
Segal BH, Herbrecht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47:674-683.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 674-683
-
-
Segal, B.H.1
Herbrecht, R.2
Stevens, D.A.3
|